Found 44 results
Author Title Type [ Year(Asc)]
Filters: Author is Oden, N  [Clear All Filters]
2016
L. R. Metsch, Feaster, D. J., Gooden, L., Matheson, T., Stitzer, M., Das, M., Jain, M. K., Rodriguez, A. E., Armstrong, W. S., Lucas, G. M., Nijhawan, A. E., Drainoni, M., Herrera, P., Vergara-Rodriguez, P., Jacobson, J. M., Mugavero, M. J., Sullivan, M., Daar, E. S., McMahon, D. K., Ferris, D. C., Lindblad, R., Van Veldhuisen, P., Oden, N., Castellón, P. C., Tross, S., Haynes, L. F., Douaihy, A., Sorensen, J. L., Metzger, S., Mandler, R. N., Colfax, G. N., and del Rio, C., Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial, JAMA, vol. 316, no. 2, pp. 156-170, 2016.
G. Sharma, Oden, N., Van Veldhuisen, P., and Bogenschutz, M., Hair Analysis and its Concordance with Self-Report for Drug Users Presenting in Emergency Department, Drug Alcohol Depend, 2016.
N. Oden and Van Veldhuisen, P., Interim Monitoring of Non-inferiority Trials, in Society for Clinical Trials (SCT) 37th Annual Meeting, Montreal, Quebec, Canada, 2016.
R. Lindblad, Hu, L., Oden, N., Wakim, P., Rosa, C., and Van Veldhuisen, P., Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network, J Subst Abuse Treat, vol. 70, pp. 73-80, 2016.
V. Veldhuisen P, Hu, L., Lindblad, R., Oden, N., Wakim, P., and Rosa, C., Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of 22 NIDA CTN Studies, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.
2014
N. Oden and Sharma, G., Tangency Outcomes for Clinical Trials, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
2011
I. Scott, Van Veldhuisen, P., Oden, N., Ip, M., Blodi, B., Hartnett, M., and Cohen, G., Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10, Ophthalmology, vol. 118, no. 2, pp. 345-352, 2011.
M. Bogenschutz, Donovan, D., Adinoff, B., Crandall, C., Forcehimes, A., Lindblad, R., Mandler, R., Oden, N., Perl, H., and Walker, R., Design of NIDA CTN Protocol 0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED), Am J Drug Alcohol Abuse, vol. 37, pp. 417-425, 2011.
N. Oden, Van Veldhuisen, P., Wakim, P., Trivedi, M., Somoza, E., and Lewis, D., Power of Automated Algorithms for Combining Time-Line Follow-Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials, Am J Drug Alcohol Abuse, vol. 37, pp. 350-357, 2011.
C. Chan, Ip, M., Van Veldhuisen, P., Oden, N., Scott, I., Tolentino, M., and Blodi, B., SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion, Ophthalmology, vol. 118, pp. 1364-1372, 2011.
M. Trivedi, Greer, T. L., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., Szapocznik, J., Stoutenberg, M., Rethorst, C., Warden, D., Ring, K., Walker, R., Morris, D. W., Kosinski, A. S., Kyle, T., Marcus, B., Crowell, B., Oden, N., and Nunes, E., Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) - CTN 0037: Study Protocol for a Randomized Controlled Trial, Trials, vol. 19, pp. 206-231, 2011.